Norm Mazer, M.D., Ph.D., Clinical Pharmacology, Roche, Basel
In silico modeling of cardiovascular and metabolic diseases: An integrative approach to drug development
In silico modeling of cardiovascular and metabolic diseases: An integrative approach to drug development